Category: Prostate Cancer

A New York Times reporter did solid work exposing the harms of PSA overscreening but missed something important. Between radical treatment and watchful waiting sits focal therapy: a minimally invasive, targeted option that the NCCN now recognizes, and that mpMRI makes more precise than ever. keep reading

What if the very cells meant to protect your body are being hijacked to shield a tumor? In metastatic prostate cancer, that's exactly what can happen. Researchers are now launching a clinical trial to test whether combining radiation with targeted immune drugs can break through this defense and potentially point the way toward a cure. keep reading

Prostate cancer once looked simple. It isn't. Science now knows there are at least 15 distinct cell lines, a single tumor can harbor multiple, and each patient's cancer behaves differently. Genomic biomarker tests are changing how doctors navigate that complexity, defining risk more precisely and helping tailor treatment to the individual. keep reading

In a murder mystery, the killer is often hiding in plain sight. The same can happen with prostate cancer. In 10-15% of cases that appear low risk, hidden aggressive disease is waiting for an unexpected twist. A deeper diagnostic workup—mpMRI, genomic analysis, and other tools—can reveal the true nature of the disease before a treatment plan is locked in. keep reading

Less than a third of men with a PSA result in the "gray zone" of 4–10 actually have prostate cancer. Yet for years, that number alone sent patients straight to biopsy. Today, mpMRI offers a smarter first step and a newly FDA-approved blood test called IsoPSA may be the safety net for cases MRI can't fully resolve. keep reading

What do prostate cancer and heart disease share? More than most men realize. Both are fueled by poor lifestyle habits that create a disease-fostering environment in the body — but both can also be fought with the same powerful tool. Research on 802 cancer survivors points to the Mediterranean Diet as a key ally in long-term survival. keep reading

Smoking raises prostate cancer risk by 40–60% — most men know that. But what about the air outside your door? A Canadian study found that two common pollutants, PM2.5 and nitrogen dioxide, are linked to higher PCa risk even in men who've never smoked. And a 2025 European report warns a far broader chemical threat is quietly building. keep reading

Prostate cancer patients benefit from personalized exercise plans, including resistance training, aerobic activity, and high-intensity intervals. Each type of exercise brings unique advantages—supporting strength, cardiovascular health, recovery, and overall well-being. keep reading

Multifocality has shaped prostate cancer treatment for years, but research shows some cases are unifocal and may qualify for less invasive focal therapy. Careful clinical evaluation is key to tailoring the best treatment approach. keep reading

Evidence shows that lifestyle changes like plant-based eating, regular activity, and stress management can influence prostate cancer outcomes and even affect gene expression. Studies indicate these habits may slow disease progression and offer additional health benefits. keep reading